Severity and threshold of peanut reactivity during hospital‐based open oral food challenges: An international multicenter survey
- 19 July 2018
- journal article
- research article
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 29 (7), 754-761
- https://doi.org/10.1111/pai.12959
Abstract
Background Peanut allergy is classically managed by food avoidance. Immunotherapy programmes are available at some academic centers for selected patients reacting to small amounts of peanut during food challenge. We aimed to determine and compare reaction thresholds and prevalence of anaphylaxis during peanut oral challenges at multiple specialist allergy centers. Methods A retrospective, international survey of anonymized case records from seven specialist paediatric allergy centers from the UK and Ireland, as well as the Australian HealthNuts study. Demographic information, allergy test results, reaction severity and threshold during open oral peanut challenges were collated and analysed. Results Of the 1,634 children aged 1 to 18 years old included, 525 (32%) failed their peanut challenge. 28% reacted to 25mg, while 38% only reacted after consuming 1g or more of whole peanut. Anaphylaxis (55 (11%)) was 3‐times more common in teenagers than younger children and the likelihood increased at all ages as children consuming more peanut at the challenge. Children who developed anaphylaxis to smaller 25–200mg whole peanut were significantly older. Previous history of reaction did not predict reaction threshold or severity. Conclusions More than a third of the children in this large international cohort tolerated the equivalent of one peanut in an oral challenge. Anaphylaxis, particularly to small amounts of peanut was more common in older children. Tailored immunotherapy programmes might be considered not only for children with low, but also higher reaction thresholds. Whether these programmes could prevent heightened sensitivity and anaphylaxis to peanut with age also deserves further study.Keywords
Funding Information
- Ilhan Food Allergy Foundation
- National Health and Medical Research Council
This publication has 29 references indexed in Scilit:
- EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergyAllergy, 2018
- Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and managementJournal of Allergy and Clinical Immunology, 2018
- BSACI guideline for the diagnosis and management of peanut and tree nut allergyClinical and Experimental Allergy, 2017
- Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adultsJournal of Allergy and Clinical Immunology, 2016
- Early oral immunotherapy in peanut-allergic preschool children is safe and highly effectiveJournal of Allergy and Clinical Immunology, 2016
- Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapyJournal of Allergy and Clinical Immunology, 2016
- Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trialJournal of Allergy and Clinical Immunology, 2015
- A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergyJournal of Allergy and Clinical Immunology, 2014
- Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapyJournal of Allergy and Clinical Immunology, 2013
- Efficacy and safety of high‐dose peanut oral immunotherapy with factors predicting outcomeClinical and Experimental Allergy, 2011